Biochemical Markers of Tumor Cell Sensitivity to L-Asparaginase

Burke, M.J. and Zalewska-Szewczyk, B., Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: Immunology and clinical consequences, Future Oncol, 2022, vol. 18, pp. 1285–1299. https://doi.org/10.2217/fon-2021-1288

Article  CAS  PubMed  Google Scholar 

Ko, R.H., Jones, T.L., Radvinsky, D., Robison, N., Gaynon, P.S., Panosyan, E.H., Avramis, I.A., Avramis, V.I., Rubin, J., Ettinger, L.J., Seibel, N.L., and Dhall, G., Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children’s oncology group report, Cancer, 2015, vol. 121, pp. 4205–4211. https://doi.org/10.1002/cncr.29641

Article  CAS  PubMed  Google Scholar 

Rau, R.E., Dreyer, Z., Choi, M.R., Liang, W., Skowronski, R., Allamneni, K.P., Devidas, M., Raetz, E.A., Adamson, P.C., Blaney, S.M., Loh, M.L., and Hunger, S.P., Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children’s Oncology Group, Pediatr. Blood Cancer, 2018, vol. 65, p. e26873. https://doi.org/10.1002/pbc.26873

Sandley, M. and Angus, J., Asparaginase therapy in patients with acute lymphoblastic leukemia: Expert opinion on use and toxicity management, Leuk. Lymphoma, 2023, vol. 64, pp. 776–787. https://doi.org/10.1080/10428194.2023.2171267

Article  CAS  PubMed  Google Scholar 

Wang, B., Relling, M.V., Storm, M.C., Woo, M.H., Ribeiro, R., Pui, C.H., and Hak, L.J., Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients, Leukemia, 2003, vol. 17, pp. 1583–1588. https://doi.org/10.1038/sj.leu.2403011

Article  CAS  PubMed  Google Scholar 

Woo, M.H., Hak, L.J., Storm, M.C., Evans, W.E., Sandlund, J.T., Rivera, G.K., Wang, B., Pui, C.H., and Relling, M.V., Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia, Leukemia, 1998, vol. 12, pp. 1527–1533. https://doi.org/10.1038/sj.leu.2401162

Article  CAS  PubMed  Google Scholar 

Van Trimpont, M., Peeters, E., De Visser, Y., Schalk, A.M., Mondelaers, V., De Moerloose, B., Lavie, A., Lammens, T., Goossens, S., and Van Vlierberghe, P., Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy, Cancers (Basel), 2022, vol. 14, p. 902. https://doi.org/10.3390/cancers14040902

Hammel, P., Fabienne, P., Mineur, L., Metges, J.P., Andre, T., De La Fouchardiere, C., Louvet, C., El Hajbi, F., Faroux, R., Guimbaud, R., Tougeron, D., Bouche, O., Lecomte, T., Rebischung, C., Tournigand, C., Cros, J., Kay, R., Hamm, A., Gupta, A., Bachet, J.B., and El Hariry, I., Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial, Eur. J. Cancer, 2020, vol. 124, pp. 91–101. https://doi.org/10.1016/j.ejca.2019.10.020

Article  CAS  PubMed  Google Scholar 

Hortobagyi, G.N., Yap, H.Y., Wiseman, C.L., Blumenschein, G.R., Buzdar, A.U., Legha, S.S., Gutterman, J.U., Hersh, E.M., and Bodey, G.P., Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine, Cancer Treat. Rep., 1980, vol. 64, pp. 157–159.

CAS  PubMed  Google Scholar 

Yap, H.Y., Benjamin, R.S., Blumenschein, G.R., Hortobagyi, G.N., Tashima, C.K., Buzdar, A.U., and Bodey, G.P., Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer, Cancer Treat. Rep., 1979, vol. 63, pp. 77–83.

CAS  PubMed  Google Scholar 

Rudnick, S.A., Neijstrom, E., Capizzi, R.L., Delaney, D., and Kirsch, M., Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung, Cancer Treat. Rep., 1982, vol. 66, pp. 541–544.

CAS  PubMed  Google Scholar 

Broome, J.D., Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: Differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells, J. Exp. Med., 1968, vol. 127, pp. 1055–1072. https://doi.org/10.1084/jem.127.6.1055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nelson, D.L. and Cox, M.M., Lehninger Principles of Biochemistry, 3 vols., vol. 2: Bioenergy and Metabolism, New York: Freeman, 2013.

https://www.uniprot.org/uniprotkb/P08243/entry. Cited November 17, 2023.

Lee, M.B. and Bridges, J.M., L-Asparaginase activity in human and animal sera, Nature, 1968, vol. 217, pp. 758–759. https://doi.org/10.1038/217758a0

Article  CAS  PubMed  Google Scholar 

De Morais, S.B. and De Souza, T., Human L‑asparaginase: Acquiring knowledge of its activation (review), Int. J. Oncol., 2021, vol. 58, no. 4, p. 11. https://doi.org/10.3892/ijo.2021.5191

Oinonen, C., Tikkanen, R., Rouvinen, J., and Peltonen, L., Three-dimensional structure of human lysosomal aspartylglucosaminidase, Nat. Struct. Biol., 1995, vol. 2, pp. 1102–1108. https://doi.org/10.1038/nsb1295-1102

Article  CAS  PubMed  Google Scholar 

https://www.uniprot.org/uniprotkb/P20933/entry. Cited November 17, 2023.

Sugimoto, H., Odani, S., and Yamashita, S., Cloning and expression of cDNA encoding rat liver 60-kDa lysophospholipase containing an asparaginase-like region and ankyrin repeat, J. Biol. Chem., 1998, vol. 273, pp. 12536–12542. https://doi.org/10.1074/jbc.273.20.12536

Article  CAS  PubMed  Google Scholar 

https://www.uniprot.org/uniprotkb/Q86U10/entry. Cited November 17, 2023.

https://www.uniprot.org/uniprotkb/Q7L266/entry. Cited November 17, 2023.

Aswad, D.W., Paranandi, M.V., and Schurter, B.T., Isoaspartate in peptides and proteins: Formation, significance, and analysis, J. Pharm. Biomed. Anal., 2000, vol. 21, pp. 1129–1136. https://doi.org/10.1016/s0731-7085(99)00230-7

Article  CAS  PubMed  Google Scholar 

Dieterich, D.C., Landwehr, M., Reissner, C., Smalla, K.H., Richter, K., Wolf, G., Bockers, T.M., Gundelfinger, E.D., and Kreutz, M.R., Gliap–A novel untypical L-asparaginase localized to rat brain astrocytes, J. Neurochem., 2003, vol. 85, pp. 1117–1125. https://doi.org/10.1046/j.1471-4159.2003.01766.x

Article  CAS  PubMed  Google Scholar 

Su, Y., Karamitros, C.S., Nomme, J., McSorley, T., Konrad, M., and Lavie, A., Free glycine accelerates the autoproteolytic activation of human asparaginase, Chem. Biol., 2013, vol. 20, pp. 533–540. https://doi.org/10.1016/j.chembiol.2013.03.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, W., Irani, S., Crutchfield, A., Hodge, K., Matthews, W., Patel, P., Zhang, Y.J., and Stone, E., Intramolecular cleavage of the hASRGL1 homodimer occurs in two stages, Biochemistry, 2016, vol. 55, pp. 960–969. https://doi.org/10.1021/acs.biochem.5b01157

Article  CAS  PubMed  Google Scholar 

Nomme, J., Su, Y., Konrad, M., and Lavie, A., Structures of apo and product-bound human L-asparaginase: Insights into the mechanism of autoproteolysis and substrate hydrolysis, Biochemistry, 2012, vol. 51, pp. 6816–6826. https://doi.org/10.1021/bi300870g

Article  CAS  PubMed  Google Scholar 

Morais, S.B., Pirolla, R.A.S., Frota, N.F., Lourenzoni, M.R., Gozzo, F.C., and Souza, T., The role of the quaternary structure in the activation of human L-asparaginase, J. Proteomics, 2020, vol. 224, p. 103818. https://doi.org/10.1016/j.jprot.2020.103818

Article  CAS  PubMed  Google Scholar 

Nomme, J., Su, Y., and Lavie, A., Elucidation of the specific function of the conserved threonine triad responsible for human L-asparaginase autocleavage and substrate hydrolysis, J. Mol. Biol., 2014, vol. 426, pp. 2471–2485. https://doi.org/10.1016/j.jmb.2014.04.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, B.S., Gu, L.J., Luo, C.Y., Li, W.S., Jiang, L.M., Shen, S.H., Jiang, H., Shen, S.H., Zhang, B., Chen, J., Xue, H.L., and Tang, J.Y., The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase, Leukemia, 2006, vol. 20, pp. 2199–2201. https://doi.org/10.1038/sj.leu.2404423

Article  CAS  PubMed  Google Scholar 

Irino, T., Kitoh, T., Koami, K., Kashima, T., Mukai, K., Takeuchi, E., Hongo, T., Nakahata, T., Schuster, S.M., and Osaka, M., Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression, J. Mol. Diagn., 2004, vol. 6, pp. 217–224. https://doi.org/10.1016/S1525-1578(10)60513-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scherf, U., Ross, D.T., Waltham, M., Smith, L.H., Lee, J.K., Tanabe, L., Kohn, K.W., Reinhold, W.C., Myers, T.G., Andrews, D.T., Scudiero, D.A., Eisen, M.B., Sausville, E.A., Pommier, Y., Botstein, D., Brown, P.O., and Weinstein, J.N., A gene expression database for the molecular pharmacology of cancer, Nat. Genet., 2000, vol. 24, pp. 236–244. https://doi.org/10.1038/73439

Article  CAS  PubMed  Google Scholar 

Li, B.S., He, Y.Y., Luo, C.Y., Jiang, H., Shen, S.H., Jiang, L.M., Zhang, B., and Gu, L.J., Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2010, vol. 18, pp. 559–563.

PubMed  Google Scholar 

Liu, W.J., Wang, H., Peng, X.W., Wang, W.D., Liu, N.W., Wang, Y., and Lu, Y., Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro, OncoTargets Ther., 2018, vol. 11, pp. 6605–6615. https://doi.org/10.2147/OTT.S155930

Article  CAS  Google Scholar 

Leslie, M., Case, M.C., Hall, A.G., and Coulthard, S.A., Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia, Br. J. Haematol., 2006, vol. 132, pp. 740–742. https://doi.org/10.1111/j.1365-2141.2005.05945.x

Article  CAS  PubMed  Google Scholar 

Aslanian, A.M., Fletcher, B.S., and Kilberg, M.S., Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells, Biochem. J., 2001, vol. 357, pp. 321–328. https://doi.org/10.1042/0264-6021:3570321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hutson, R.G., Kitoh, T., Moraga Amador, D.A., Cosic, S., Schuster, S.M., and Kilberg, M.S., Amino acid control of asparagine synthetase: Relation to asparaginase resistance in human leukemia cells, Am. J. Physiol., 1997, vol. 272, pp. C1691–C1699. https://doi.org/10.1152/ajpcell.1997.272.5.C1691

Article  CAS  PubMed  Google Scholar 

Kiriyama, Y., Kubota, M., Takimoto, T., Kitoh, T., Tanizawa, A., Akiyama, Y., and Mikawa, H., Biochemical characterization of U937 cells resistant to L-asparaginase: The role of asparagine synthetase, Leukemia, 1989, vol. 3, pp. 294–297.

CAS  PubMed  Google Scholar 

Hermanova, I., Zaliova, M., Trka, J., and Starkova, J., Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase, Exp. Hematol., 2012, vol. 40, pp. 657–665.

留言 (0)

沒有登入
gif